
The PD-1/PD-L1 pathway in advanced prostate cancer—have we milked this cow?
Author(s) -
Sarah Picardo,
Aaron Richard Hansen
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.05.86
Subject(s) - pembrolizumab , prostate cancer , medicine , immunotherapy , cancer , oncology , pd l1 , lung cancer , melanoma , cancer research